|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2064239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07842088.2 |
| Date of filing the European patent application | 2007-09-07 | |
| (97) | Date of publication of the European application | 2009-06-03 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-26 |
| (46) | Date of publication of the claims translation | 2015-03-25 |
| (86) | Number | PCT/US2007/077923 |
| Date | 2007-09-07 |
| (87) | Number | WO 2008/031061 |
| Date | 2008-03-13 |
| (30) | Number | Date | Country code |
| 843430 P | 2006-09-08 | US | |
| 956653 P | 2007-08-17 | US |
| (72) |
HAN, Hq, US
CHEN, Qing, US
KWAK, Keith, Soo-Nyung, US
ZHOU, Xiaolan, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive Thousand Oaks, California 91320,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnai prieš aktiviną A ir jų panaudojimai |
| ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-08-20 | 19 | 347.00 EUR |
| 2026-09-07 |